PAUL CARNES: Open Payments
NPI 1417940990 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,432 in 135 payments from 24 companies in 2025. Trend: 2023 $1,938 · 2024 $3,413 · 2025 $5,432
Food & beverage: $4,751Travel & lodging: $680
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 39 | $2,179 |
| BIOTRONIK NRO, Inc. | 20 | $1,081 |
| Medtronic, Inc. | 8 | $545 |
| Averitas Pharma Inc. | 13 | $449 |
| ABBVIE INC. | 11 | $222 |
| Lundbeck LLC | 6 | $182 |
| Neurocrine BioSciences, Inc. | 4 | $97 |
| Abbott Laboratories | 3 | $80 |
| Alexion Pharmaceuticals, Inc. | 3 | $74 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
Products named: WaveWriter Alpha Prime 16, Prospera, QUTENZA, KYPHON EXPRESS II KYPHOPAK TRAY, VYEPTI, UBRELVY, QULIPTA, INGREZZA.
Industry payments across NC — which companies pay providers there.
